Analysts have lowered their revenue forecasts for First Advantage following recent results, with a significant cut to EPS numbers. Despite this, the consensus price target remains unchanged, indicating analysts don't see a significant impact on the company's intrinsic value. However, the company's revenue growth is expected to slow, underperforming the wider industry.
First Advantage's ROCE rise signals improved efficiency, but flat capital employed may hint at limited internal investment opportunities for organic growth. The stock's 33% gain over the past year indicates growing attention to these developments.
First Advantage showed substantial earnings growth due to high reinvestment despite low ROE. Future earnings growth may decrease, but there is long-term resilience potential based on strategic decisions and effective reinvestment strategy.
JPMorgan Downgrades Nu Holdings on Concerning Trends into Q3 Report JPMorgan analyst Domingos Falavina downgraded$Nu Holdings (NU.US)$to Underweight from Neutral without a price target. "Recent reports from other large cap banks in Brazil have been concerning to us," Falavina tells investors in a research note. First Advantage Downgraded to Equal Weight From Overweight at Barclays Barclays analyst Manav Patnaik downgraded$First Advantage (FA.US)$to Equal ...
12
3
Report
Seewhy84
:
Without solid backing from the Q3 report, just concerning trend lead to massive sell down. What a joke, JP Morgan analyst. Nothing substantial, another trap to let people sell down, while they buy up quietly,
Moomoopedia SG
Cash88
:
IPO subscription is currently not available in Singapore. But Singapore users can subscribe to US IPOs in a few weeks! Please keep up with future updates.
First Advantage Stock Forum
JPMorgan analyst Domingos Falavina downgraded $Nu Holdings (NU.US)$ to Underweight from Neutral without a price target. "Recent reports from other large cap banks in Brazil have been concerning to us," Falavina tells investors in a research note.
First Advantage Downgraded to Equal Weight From Overweight at Barclays
Barclays analyst Manav Patnaik downgraded $First Advantage (FA.US)$ to Equal ...
• $First Advantage (FA.US)$ +5.59%, $General Mills (GIS.US)$ +3.06%, $Privia Health (PRVA.US)$+1.1% (also names new CFO).
Other news:
• $GameStop (GME.US)$ +12.1% (continued strength; RC Ventures (Ryan Cohen) increases active stake to 11.9%)
• $Aurora Cannabis (ACB.US)$ +7.6% (acquires Terra Fa rm a for $38 mln)
• $Opera (OPRA.US)$ +4.9% (sells 42.35% ownership interest in Nanobank for $127,1 mln)
• $MorphoSys (MOR.US)$ +2.8% (MOR and INC...
No comment yet